Jazz Pharmaceuticals PLC

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

121.69%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-5.18 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE217.6 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 01:50:53 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW218.4217.1
PREV. DAY'S PRICE219.3 (07/22)
CHANGE DAY BEFORE
-1.70
-0.78 %
52 WEEK HIGH / LOW224.9 (07/22)89.68 (08/07)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
5.648.00-5.1822.2122.79
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
20.1614.2420.29(e)10.049.78
PRICE - BOOK RATIO
2.051.822.42--
PRICE - SALES RATIO
2.312.002.43--
PRICE - CASH FLOW RATIO
8.125.827.65--
Further Key Figures

Master Data

WKN
A1JS1K
ISIN
IE00B4Q5ZN47
SYMBOL
J7Z
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
JAZZ PHARMACEUT. DL-,0001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
4.88 %
11.15 %
27.31 %
50.83 %
121.69 %
92.88 %
48.58 %
53.46 %
HIGH224.90224.90224.90224.90224.90224.90224.90224.90
LOW204.60193.00165.00134.3589.6886.3686.36134.35

Dividende

pro Aktie
JAZZ PHARMACEUT. DL-,0001 does not deliver dividend information

Company profile

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.